Comprehensive asthma management: guidelines for clinicians (Q39442838)

12 September 2017

1 reference

title

Comprehensive asthma management: guidelines for clinicians (English)

1 reference

12 September 2017

0 references

Kemp JP

1

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

12 September 2017

1 reference

12 September 2017

volume

35

1 reference

12 September 2017

issue

8

1 reference

12 September 2017

page(s)

601-620

1 reference

Pathology of asthma and its clinical implications

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Cytokines and airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

The late asthmatic response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

21 January 2018

Late asthmatic responses

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Potential adverse endocrine effects of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Phosphodiesterase inhibitors: new opportunities for the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Goals of asthma management. A step-care approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Steroid-resistant asthma: evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Environmental control and immunotherapy for allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Environmental control of asthma self-management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Chemokinetic activity of arachidonic acid lipoxygenase products on leuocyctes of different species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Platelet-activating factor as a mediator of allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream").

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770909809048963

10.3109/02770909809048963

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference